Vancomycin resistance in enterococci: Reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis

Chemistry and Biology

Volumn 7, Issue 5, 2000, Pages

  Healy, Vicki L ^a   Lessard, Ivan A D ^b   Roper, David I ^c   Knox, James R ^d   Walsh, Christopher T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Boehringer Ingelheim Canada   (Canada)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS;

EID: 0034087501     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00116-2     Document Type: Review

References (63)

1. Arthur M., Depardieu F., Reynolds P., Courvalin P. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol. Microbiol. 21:1996;33-44.
2. Barna J.C.J., Williams D.H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol. 38:1984;339-357.
3. Arthur M., Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1993;1563-1571.
4. Reynolds P.E. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Microb. Infect. Dis. 8:1989;943-950.
5. Walsh C.T. Vancomycin resistance: decoding the molecular logic. Science. 261:1993;308-309.
6. Neu H.C. The crisis in antibiotic resistance. Science. 257:1992;1063-1073.
7. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. N. Engl. J. Med. 330:1994;1247-1251.
8. Swartz M.N. Hospital-acquired infections: diseases with increasingly limited therapies. Proc. Natl Acad. Sci. USA. 91:1994;2420-2427.
9. Iwakawa K., Tsusaka N., Kizu J., Yamamoto K. Selection of methicillin-resistant Staphylococcus aureus following increased use of vancomycin despite restricted use of third generation cephem. Jpn. J. Infect. Dis. 52:1999;221-222.
10. Hoeffler D., Zimmermann U. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Lancet. 350:1997;737-739.
11. Dutka-Malen S., Molinas C., Arthur M., Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene. 112:1992;53-58.
12. Bugg T.D., Wright G.D., Dutka-Malen S., Arthur M., Courvalin P., Walsh C.T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry. 30:1991;10408-10415.
13. Navarro F., Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob. Agents Chemother. 38:1994;1788-1793.
14. Billot-Klein D., Blanot D., Gutmann L., van Heijenoort J. Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine. Biochem. J. 304:1994;1021-1022.
15. Perichon B., Reynolds P., Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob. Agents Chemother. 41:1997;2016-2018.
16. Fines M., Perichon B., Reynolds P., Sahm D.F., Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob. Agents Chemother. 43:1999;2161-2164.
17. Lessard I.A.D., Healy V.L., Park I.S., Walsh C.T. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci. Biochemistry. 38:1999;14006-14022.
18. Shi Y., Walsh C.T. Active site mapping of Escherichia coli D-Ala-D-Ala ligase by structure based mutagenesis. Biochemistry. 34:1995;2768-2776.
19. Fan C., Moews P.C., Walsh C.T., Knox J.R. Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 Å resolution. Science. 266:1994;439-443.
20. Park I.S., Walsh C.T. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation. J. Biol. Chem. 272:1997;9210-9214.
21. Fan C., Moews P.C., Walsh C.T., Knox J.R. A common fold for peptide synthetases cleaving ATP to ADP: glutathione synthetase and D-alanine:D-alanine ligase of Escherichia coli. Proc. Natl Acad. Sci. USA. 92:1995;1172-1176.
22. Artymiuk P.J., Poirrette A.R., Rice D.W., Willett P. Biotin carboxylase comes into the fold. Nat. Struct. Biol. 3:1996;128-132.
23. Thoden J.B., Holden H.M., Wesenberg G., Raushel F.M., Rayment I. Structure of carbamoyl phosphate synthetase: a journey of 96 Å from substrate to product. Biochemistry. 36:1997;6305-6316.
24. Denessiouk K.A., Lehtonen J.V., Johnson M.S. Enzyme-mononucleotide interactions: three different folds share common structural elements for ATP recognition. Protein Sci. 7:1998;1768-1771.
25. Galperin M.Y., Koonin E.V. A diverse superfamily of enzymes with ATP-dependent carboxylate-amine/thiol ligase activity. Protein Sci. 6:1997;2639-2643.
26. Mullins L.S., Zawadzke L.E., Walsh C.T., Raushel F.M. Kinetic evidence for the formation of D-alanyl phosphate in the mechanism of D-alanyl-D-alanine ligase. J. Biol. Chem. 265:1990;8993-9899.
27. Ogita T., Knowles J.R. On the intermediacy of carboxyphosphate in biotin-dependent carboxylations. Biochemistry. 27:1988;8028-8033.
28. Gushima H., Miya T., Murata K., Kimura A. Purification and characterization of glutathione synthetase from Escherichia coli B. J. Appl. Biochem. 5:1983;210-218.
29. Marolewski A.E., Mattia K.M., Warren M.S., Benkovic S.J. Formyl phosphate: a proposed intermediate in the reaction catalyzed by Escherichia coli PurT GAR transformylase. Biochemistry. 36:1997;6709-6716.
30. Wright G.D., Walsh C.T. Identification of a common protease-sensitive region in D-alanyl-D-alanine and D-alanyl-D-lactate ligases and photoaffinity labeling with 8-azido ATP. Protein Sci. 2:1993;1765-1769.
31. Park I.S., Lin C.H., Walsh C.T. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B. Biochemistry. 35:1996;10464-10471.
32. Carlson H.A., Briggs J.M., McCammon J.A. Calculation of the pKa values for the ligands and side chains of Escherichia coli D-alanine:D-alanine ligase. J. Med. Chem. 42:1999;109-117.
33. Park J.T. Murein synthesis. Neidhardt F.C. Escherichia coli and Salmonella typhimurium. 1987;663-671 American Society for Microbiology, Washington.
34. Marshall C.G., Wright G.D. DdlN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity. J. Bacteriol. 180:1998;5792-5795.
35. Marshall C.G., Broadhead G., Leskiw B.K., Wright G.D. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc. Natl Acad. Sci. USA. 94:1997;6480-6483.
36. Marshall C.G., Lessard I.A., Park I.S., Wright G.D. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 42:1998;2215-2220.
37. Handwerger S., Pucci M.J., Volk K.J., Liu J., Lee M.S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J. Bacteriol. 176:1994;260-264.
38. Billot-Klein D., Gutmann L., Sable S., Guittet E., van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low- level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J. Bacteriol. 176:1994;2398-2405.
39. Kuzin A.P., Sun T., Jorczak-Baillass J., Healy V.L., Walsh C.T., Knox J.R. Enzymes of vancomycin resistance. The structure of D-Alanine:D-lactate ligase of naturally-resistant Leuconostoc mesenteroides. Structure. 2000;. in press.
40. Dutka-Malen S., Leclercq R., Coutant V., Duval J., Courvalin P. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob. Agents Chemother. 34:1990;1875-1879.
41. Park I.S., Lin C., Walsh C.T. Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase. Proc. Natl Acad. Sci. USA. 94:1997;10040-10044.
42. Healy V.L., Park I.S., Walsh C.T. Active-site mutants of the VanC2 D-alanyl-D-serine ligase, characteristic of one vancomycin-resistant bacterial phenotype, revert towards wild-type D-alanyl-D-alanine ligases. Chem. Biol. 5:1998;197-207.
43. Duncan K., van Heijenoort J., Walsh C.T. Purification and characterization of the D-alanyl-D-alanine-adding enzyme from Escherichia coli. Biochemistry. 29:1990;2379-2386.
44. Arthur M., Molinas C., Depardieu F., Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:1993;117-127.
45. Reynolds P.E., Depardieu F., Dutka-Malen S., Arthur M., Courvalin P. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol. Microbiol. 13:1994;1065-1070.
46. Wu Z., Wright G.D., Walsh C.T. Overexpression, purification, and characterization of VanX, a D-, D- dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry. 34:1995;2455-2463.
47. Arthur M., Depardieu F., Snaith H.A., Reynolds P.E., Courvalin P. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Antimicrob. Agents Chemother. 38:1994;1899-1903.
48. Reynolds P.E., Arias C.A., Courvalin P. Gene vanXYC encodes D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol. Microbiol. 34:1999;341-349.
49. Bussiere D.E., Pratt S.D., Katz L., Severin J.M., Holzman T., Park C.H. The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol. Cell. 2:1998;75-84.
50. Lessard I.A.D., Walsh C.T. Mutational analysis of active-site residues of the enterococcal D-Ala-D-Ala dipeptidase VanX and comparison with Escherichia coli D-Ala-D-Ala ligase and D-Ala-D-Ala carboxypeptidase VanY. Chem. Biol. 6:1999;177-187.
51. Arthur M., Molinas C., Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174:1992;2582-2591.
52. Holman T.R., Wu Z., Wanner B.L., Walsh C.T. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. Biochemistry. 33:1994;4625-4631.
53. Arias C.A., Martin-Martinez M., Blundell T.L., Arhur M., Courvalin P., Reynolds P.E. Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol. Microbiol. 31:1999;1653-1664.
54. Ellsworth B.A., Tom N.J., Bartlett P.A. Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. Chem. Biol. 3:1996;37-44.
55. Barrett J.F., Hoch J.A. Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob. Agents Chemother. 42:1998;1529-1536.
56. Biavasco F., Vignaroli C., Lupidi R., Manso E., Facinelli B., Varaldo P.E. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Antimicrob. Agents Chemother. 41:1997;2165-2172.
57. Moellering R.C. Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections. J. Antimicrob. Agents Chemother. 44:1999;25-30.
58. Kurz M., Guba W. 3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis. Biochemistry. 35:1996;12570-12575.
59. Chang Y.T., Schultz P.G.et al. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem. Biol. 6:1999;361-375.
60. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22:1994;4673-4680.
61. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;945-949.
62. Wild J., Henning J., Lobocka M., Walczak W., Klopotowski T. Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12. Mol. Gen. Genet. 198:1985;315-9999.
63. Marshall C.G., Wright G.D. The glycopeptide antibiotic producer Streptomyces toyocaensis NRRL 15009 has both D-alanyl-D-alanine and D-alanyl-D-lactate ligases. FEMS Microb. Let. 157:1997;295-299.